Your session is about to expire
← Back to Search
68Ga-PSMA Scan for Prostate Cancer (PSMA Trial)
Phase 2
Waitlist Available
Led By Rodolfo Nunez, MD
Research Sponsored by Ebrahim Delpassand
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
PSMA Trial Summary
This trial is testing a new PET-CT scan to see how well it can detect prostate cancer tumors.
Eligible Conditions
- Prostate Cancer
PSMA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The sensitivity of 68Ga-PSMA-11 PET for detection of tumor location.
Secondary outcome measures
Detection rates of 68Ga-PSMA-11 PET in patients with different PSA value
PSMA Trial Design
1Treatment groups
Experimental Treatment
Group I: 68Ga-PSMAExperimental Treatment1 Intervention
Evaluation of concordance and discordance between the results of 68Ga-PSMA PET/CT and other available conventional imaging modalities (such as CT, MRI, FDG, NaF scan), histology or follow up.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
68Ga-PSMA
2018
Completed Phase 2
~1580
Find a Location
Who is running the clinical trial?
Ebrahim DelpassandLead Sponsor
Radiomedix, Inc.Industry Sponsor
6 Previous Clinical Trials
561 Total Patients Enrolled
Excel Diagnostics and Nuclear Oncology CenterOTHER
5 Previous Clinical Trials
455 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You had any other type of cancer in the past 2 years, except for non-invasive skin or bladder cancer.You have received treatment for prostate cancer with an experimental drug for less than two months.You received chemotherapy or radiation therapy, or had a procedure called focal ablation (HiFu) for your prostate cancer within the last 2 months before the study.
Research Study Groups:
This trial has the following groups:- Group 1: 68Ga-PSMA
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many potential participants are being considered for this research?
"That is correct. The information available on clinicaltrials.gov indicates that the study is still recruiting patients. This particular trial was posted on 05/01/2015 and was edited as recently as 08/17/2020. There is 1 location participating in this trial and they are looking for a total of 208 patients."
Answered by AI
Does 68Ga-PSMA put individuals at risk?
"68Ga-PSMA's safety is unknown but there is some evidence from Phase 2 trials that it may be safe."
Answered by AI
Is there still room for test subjects in this experiment?
"That is correct. The clinicaltrials.gov website suggests that this study, which was posted on May 1st 2015 and last edited on August 17th 2020, is actively looking for 208 participants from 1 site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger